Capstone Investment Advisors’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-200,000
Closed -$2.01M 1741
2022
Q4
$2.01M Hold
200,000
0.01% 706
2022
Q3
$1.96M Hold
200,000
0.01% 764
2022
Q2
$1.96M Hold
200,000
0.01% 771
2022
Q1
$1.95M Hold
200,000
0.01% 1067
2021
Q4
$1.95M Hold
200,000
﹤0.01% 1123
2021
Q3
$1.94M Hold
200,000
﹤0.01% 1213
2021
Q2
$1.95M Buy
+200,000
New +$1.96M ﹤0.01% 1039

Other funds holding AONC

Capstone Investment Advisors's AONC Position: Q1 2023 in Review

Capstone Investment Advisors sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 200,000 shares — an estimated $2.01M sold.

Capstone Investment Advisors first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $2.01M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Capstone Investment Advisors reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Capstone Investment Advisors sold 200,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $2.01M.
  • Capstone Investment Advisors first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Capstone Investment Advisors's American Oncology Network, Inc. Class A Common Stock position peaked at $2.01M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Capstone Investment Advisors's 13F filing for Q1 2023, filed 9 May 2023.